TarunKewalramaniMD

PubMed

• 9 citations
  Acute Myeloid Leukemia After Radium-223 Therapy: Case Report.
  Andreas Varkaris, Krishna S Gunturu, Tarun Kewalramani, Christopher Tretter> ;Clinical Genitourinary Cancer. 2017 Aug 1
• 278 citations
  Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
  Tarun Kewalramani, Andrew D. Zelenetz, Stephen D. Nimer, Carol S. Portlock, David J. Straus, Ariela Noy, Owen A. O'Connor, Daniel A. Filippa, Julie Teruya-Feldstein, A...> ;Blood. 2004 May 15
• 36 citations
  Autologous stem cell transplant recipients tolerate haploidentical related-donor natural killer cell-enriched infusions.
  Hans G. Klingemann, Carrie Grodman, Elliott Cutler, Marvin Duque, Diane Kadidlo, Andreas K. Klein, Kellie Sprague, Kenneth B. Miller, Raymond L. Comenzo, Tarun Kewalra...> ;Transfusion. 2013 Feb 1
• 45 citations
  Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma.
  James R. Berenson, Ori Yellin, Alberto Bessudo, Ralph V. Boccia, Stephen J. Noga, Donald S. Gravenor, Dipti Patel-Donnelly, Robert S. Siegel, Tarun Kewalramani, Edward...> ;British Journal of Haematology. 2013 Feb 1
• Efficacy and safety of bendamustine plus bortezomib in relapsed/refractory multiple myeloma: A phase I/II trial.
  Berenson JR, Yellin O, Bessudo A, Boccia R, Noga S, Gravenor D, Patel-Donnelly D, Siegel RS, Kewalramani T, Gorak EJ, Swift R, Bensen-Kennedy D> ;J. Clin. Oncol.. 2011-05-20
• 17 citations
  Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients
  Sherry Mathew, Nelly G. Adel, R.D. Rice, Katherine S. Panageas, Elaine Duck, Raymond L. Comenzo, Tarun Kewalramani, Stephen D. Nimer> ;Bone Marrow Transplantation. 2010 Oct 1
• 166 citations
  Pretransplantation functional imaging predicts outcome following autologous stem cell transplantation for relapsed and refractory Hodgkin lymphoma
  Alison J. Moskowitz, Joachim Yahalom, Tarun Kewalramani, Jocelyn C. Maragulia, Jill M. Vanak, Andrew D. Zelenetz, Craig H. Moskowitz> ;Blood. 2010 Dec 2
• 59 citations
  High-dose chemo-radiotherapy for relapsed or refractory Hodgkin lymphoma and the significance of pre-transplant functional imaging.
  Craig H. Moskowitz, Joachim Yahalom, Andrew D. Zelenetz, Zhigang Zhang, Daniel A. Filippa, Julie Teruya-Feldstein, Tarun Kewalramani, Alison J. Moskowitz, R.D. Rice, J...> ;British Journal of Haematology. 2010 Mar 1
• 18 citations
  Second-line age-adjusted International Prognostic Index in patients with advanced non-Hodgkin lymphoma after T-cell depleted allogeneic hematopoietic SCT.
  M.-A. Perales, Robert R. Jenq, Jenna D. Goldberg, Andrew Wilton, Sinda S. Lee, Hugo Castro-Malaspina, Katharine C. Hsu, Esperanza B. Papadopoulos, M.R.M. van den Brink...> ;Bone Marrow Transplantation. 2010 Jan 11
• 111 citations
  Outcomes for patients who fail high dose chemoradiotherapy and autologous stem cell rescue for relapsed and primary refractory Hodgkin lymphoma
  Alison J. Moskowitz, Miguel-Angel Perales, Tarun Kewalramani, Joachim Yahalom, Hugo Castro-Malaspina, Zhigang Zhang, Jill M. Vanak, Andrew D. Zelenetz, Craig H. Moskowitz> ;British Journal of Haematology. 2009 Jul 1
• Phase II trial of temozolomide (TMZ) followed by myeloablative chemotherapy with autologous peripheral blood progenitor cell rescue (APBPCR) for newly diagnosed anapla...
  Kaley TJ, Raizer JJ, Paleologos N, Kewalramani T, Grimm S, Louis DN, Cairncross JG, Abrey LE> ;J. Clin. Oncol.. 2009-05-20
• Therapeutic and palliative benefit from single-agent irinotecan in multiply treated and highly refractory cases of lymphoma.
  Caces DD, Halaas J, Hamlin P, Noy A, Kewalramani T, Portlock CS, Zelenetz AD, O'Connor OA, Gerecitano JF> ;J. Clin. Oncol.. 2009-05-20
• 320 citations
  American Society of Clinical Oncology 2008 Clinical Practice Guideline Update: Use of Chemotherapy and Radiation Therapy Protectants
  Martee L. Hensley, Karen L. Hagerty, Tarun Kewalramani, Daniel M. Green, Neal J. Meropol, Todd H. Wasserman, Gary I. Cohen, Bahman Emami, William J. Gradishar, R. Bria...> ;Journal of Clinical Oncology. 2009 Jan 1
• 40 citations
  High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease.
  Hani Hassoun, Carlos D. Flombaum, Vivette D. D'Agati, B T Rafferty, Adam D. Cohen, Virginia M. Klimek, Adam Boruchov, Tarun Kewalramani, L Reich, Stephen D. Nimer, Ray...> ;Bone Marrow Transplantation. 2008 Jun 23
• 9 citations
  Reversible Fanconi syndrome due to lenalidomide
  Ilya G. Glezerman, Tarun Kewalramani, Kenar D. Jhaveri> ;Ndt Plus. 2008 Aug 1
• 8 citations
  A phase II study of intensified chemotherapy alone as initial treatment for newly diagnosed anaplastic oligodendroglioma: an interim analysis
  Nimish Mohile, Peter A. Forsyth, Douglas A. Stewart, Jeffrey J. Raizer, Nina Paleologos, Tarun Kewalramani, David N. Louis, J. Gregory Cairncross, Lauren E. Abrey> ;Journal of Neuro-oncology. 2008 May 6
• 26 citations
  Involved-Field Radiotherapy Before High-Dose Therapy and Autologous Stem-Cell Rescue in Diffuse Large-Cell Lymphoma: Long-Term Disease Control and Toxicity
  Bradford S. Hoppe, Craig H. Moskowitz, Daniel A. Filippa, Chaya S. Moskowitz, Tarun Kewalramani, Andrew D. Zelenetz, Joachim Yahalom> ;Journal of Clinical Oncology. 2008 Apr 10
• 81 citations
  Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.
  Adam D. Cohen, Ping Zhou, Joanne Chou, Julie Teruya-Feldstein, Lilian Reich, Hani Hassoun, Beth Levine, Daniel A. Filippa, Elyn Riedel, Tarun Kewalramani, Michael D. S...> ;British Journal of Haematology. 2007 Oct 1
• 83 citations
  Autologous transplantation for relapsed or primary refractory peripheral T-cell lymphoma.
  Tarun Kewalramani, Andrew D. Zelenetz, Julie Teruya-Feldstein, Paul A. Hamlin, Joachim Yahalom, Steven M. Horwitz, Stephen D. Nimer, Craig H. Moskowitz> ;British Journal of Haematology. 2006 Jul 1
• 7 citations
  Results of a phase I/II trial adding carmustine (300 mg/m2) to melphalan (200 mg/m2) in multiple myeloma patients undergoing autologous stem cell transplantation.
  Raymond L. Comenzo, Hani Hassoun, Tarun Kewalramani, Virginia M. Klimek, Madhav V. Dhodapkar, L Reich, Julie Teruya-Feldstein, Martin Fleisher, Daniel A. Filippa, Step...> ;Leukemia. 2006 Feb 1
• 1 citations
  The serum IL-12:IL-6 ratio reliably distinguishes infectious from non-infectious causes of fever during autologous stem cell transplantation
  Roman A. Tuma, Nikolaos G. Almyroudis, S. J. Sohn, Katherine S. Panageas, R.D. Rice, D. Galinkin, M. Blain, M. Montefusco, Eric G. Pamer, Stephen D. Nimer, Tarun Kewal...> ;Cytotherapy. 2006 Jan 1
• 31 citations
  Doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective well tolerated initial therapy for multiple myeloma
  Hani Hassoun, Lilian Reich, Virginia M. Klimek, Madhav V. Dhodapkar, Adam D. Cohen, Tarun Kewalramani, Rachel Zimman, Lisa Drake, Elyn Riedel, Cyrus V. Hedvat, Julie T...> ;British Journal of Haematology. 2006 Jan 1
• 60 citations
  Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with re...
  Craig H. Moskowitz, Andrew D. Zelenetz, Tarun Kewalramani, Paul A. Hamlin, Simone Lessac-Chenen, Jane Houldsworth, Adam B. Olshen, R. S. K. Chaganti, Stephen D. Nimer,...> ;Blood. 2005 Nov 15
• 13 citations
  Hematopoietic stem cell mobilization with intravenous melphalan and G-CSF in patients with chemoresponsive multiple myeloma: report of a phase II trial.
  S Gupta, Ping Zhou, Hani Hassoun, Tarun Kewalramani, L Reich, S Costello, Lynn A. Drake, Virginia M. Klimek, Madhav V. Dhodapkar, Julie Teruya-Feldstein, Cyrus V. Hedv...> ;Bone Marrow Transplantation. 2005 Mar 1
• 567 citations
  Palifermin for Oral Mucositis after Intensive Therapy for Hematologic Cancers
  Ricardo Spielberger, Patrick J. Stiff, William I. Bensinger, Teresa Gentile, Daniel J. Weisdorf, Tarun Kewalramani, Thomas B. Shea, Saul Yanovich, Keith Hansen, Stephe...> ;The New England Journal of Medicine. 2004 Dec 16
• Join now to see all